Table 1. Prophylactic fingolimod does not modify the spontaneous release of endogenous glutamate and GABA from synaptosomes isolated from selected regions of central nervous system of EAE mice at the acute stage of disease.
Control mice | Fingolimod-treated control mice | EAE mice | Fingolimod treated EAE mice | |
---|---|---|---|---|
endogenous glutamate (pmoles / mg protein) | ||||
cortex | 123.4 ± 13.7 | 132.7 ± 16.0 | 108.4 ± 15.3 | 128.1 ± 15.2 |
hippocampus | 155.9 ± 17.3 | 172.6 ± 22.4 | 182.1 ± 21.33 | 162.8 ± 16.3 |
spinal cord | 198.3 ± 22.5 | 212.4 ± 21.3 | 209.7 ± 18.4 | 203.5 ± 22.1 |
endogenous GABA (pmoles / mg protein) | ||||
cortex | 83.2 ± 11.2 | 78.9 ± 14,5 | 99.5 ± 13.5 | 89.4 ± 16.7 |
hippocampus | 75.4 ± 12.9 | 62.3 ± 9.5 | 71.5 ± 11.3 | 78.2 ± 8.3 |
spinal cord | 65.7 ± 13.5 | 72.4 ± 9.1 | 58.4 ± 11.4 | 78.3 ± 14.3 |